日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Holistic determination of ends of cfDNA molecules

cfDNA分子末端的整体测定

Jiang, Peiyong; Ma, Mary-Jane L; Qiao, Rong; Shi, Yuwei; Liu, Jing; Zhou, Qing; Peng, Wenlei; Lam, W K Jacky; Bai, Jinyue; Choy, L Y Lois; Tsui, W H Adrian; Malki, Yasine; Kang, Guannan; Yu, Stephanie C Y; Xiong, Dongyan; Wong, Grace L H; Chan, Landon L; Wong, John; Chan, Stephen L; Wong, Vincent W S; Chan, K C Allen; Lo, Y M Dennis

Radiation-induced lymphopenia is associated with survival in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy

放射性淋巴细胞减少症与接受立体定向放射治疗的肝细胞癌患者的生存率相关。

Chan, Landon L; Yeung, Vanessa T Y; Soo, Winnie M T; Poon, Darren M C; Tong, Macy; Lam, Daisy C M; Kwong, Virginia H Y; Chan, Eric K H; Ip, Aaron Y H; Cheung, Michael L M; Shum, Felix F Y; Johnson, David R; Lam, Benjamin H W; Wong, Wesley K Y; Mok, Florence S T; Chan, Stephen L

Balancing Regeneration and Resistance: Targeting DCLK1 to Mitigate Gastrointestinal Radiation Injury and Oncogenesis

平衡再生与抵抗:靶向DCLK1以减轻胃肠道放射损伤和肿瘤发生

Moore, Landon L; Jaboin, Jerry; Brown, Milton L; Houchen, Courtney W

Future perspectives on immunotherapy for hepatocellular carcinoma

肝细胞癌免疫疗法的未来展望

Chan, Landon L; Chan, Stephen L

A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growth.

一种新型 D 肽调节 DCLK1 凝溶胶蛋白相互作用,从而减少 PDAC 肿瘤生长。

Moore Landon L, Qu Dongfeng, Chandrekesan Parthasarathy, Pitts Kamille, May Randal, Anderson Byron E, Brown Milton L, Houchen Courtney W

Clinical management of liver cancer patients with immune checkpoint inhibitors treatment

免疫检查点抑制剂治疗肝癌患者的临床管理

Yau, Johnny C W; Chan, Landon L; Chan, Stephen L

Community expert insights on anticipated implementation challenges for an evidence-based adherence intervention for Black clients

社区专家就针对黑人客户的循证依从性干预措施实施过程中可能遇到的挑战提供的见解

Bogart, Laura M; Lawrence, Sean J; Beck, Amaya; Mutchler, Matt G; Ball, Amy; Thomas, Damone; Carlisle, Nicholas A; Lee, David P; Nichols, Landon L; Smith, Trevis; Wagner, Glenn J; Goggin, Kathy; MacCarthy, Sarah

A Novel D-peptide modulates DCLK1 Gelsolin interactions, reducing PDAC tumor growth.

一种新型D肽调节DCLK1与凝溶胶蛋白的相互作用,从而减少PDAC肿瘤的生长

Moore Landon L, Qu Dongfeng, Chandrekesan Parthasarathy, Pitts Kamille, May Randal, Anderson Byron E, Brown Milton, Houchen Courtney W

Next-generation immunotherapy: igniting new hope for lung cancer

新一代免疫疗法:为肺癌治疗带来新希望

Li, Molly S C; Chan, Andrew L S; Mok, Kevin K S; Chan, Landon L; Mok, Tony S K

Brief Report: Risk of Recurrent Interstitial Lung Disease From Osimertinib Versus Erlotinib Rechallenge After Symptomatic Osimertinib-Induced Interstitial Lung Disease

简报:奥希替尼诱发间质性肺病症状后再次使用奥希替尼与厄洛替尼治疗间质性肺病复发的风险比较

Li, Molly S C; Lee, Kirsty W C; Mok, Kevin K S; Loong, Herbert H F; Lam, K C; Mok, Florence S T; Chan, Landon L; Lau, Y M; Chan, K P; Ng, Joyce T Y; Wong, Wesley K Y; Lam, Benjamin H W; Chen, Allen C C; Lee, Matthew M P; Chen, Olivia H; Mok, Tony S K